Oral anticoagulants. New oral anticoagulants for atrial fibrillation: the factor Xa inhibitors rivaroxaban and apixaban
- PMID: 22565540
- DOI: 10.3909/ricm0642
Oral anticoagulants. New oral anticoagulants for atrial fibrillation: the factor Xa inhibitors rivaroxaban and apixaban
Comment on
-
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. N Engl J Med. 2011. PMID: 21830957 Clinical Trial.
-
Apixaban versus warfarin in patients with atrial fibrillation.N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27. N Engl J Med. 2011. PMID: 21870978 Clinical Trial.
Similar articles
-
Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.Lancet Haematol. 2019 Jul;6(7):e359-e365. doi: 10.1016/S2352-3026(19)30086-9. Epub 2019 May 24. Lancet Haematol. 2019. PMID: 31133411
-
Comparative Safety and Effectiveness of Oral Anticoagulants in Nonvalvular Atrial Fibrillation: The NAXOS Study.Stroke. 2020 Jul;51(7):2066-2075. doi: 10.1161/STROKEAHA.120.028825. Epub 2020 Jun 16. Stroke. 2020. PMID: 32539675 Free PMC article.
-
Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10. Circ Cardiovasc Qual Outcomes. 2012. PMID: 22787066 Free PMC article.
-
Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Adv Ther. 2012. PMID: 22684583 Review.
-
Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.Curr Opin Cardiol. 2010 Jul;25(4):312-20. doi: 10.1097/HCO.0b013e32833a524f. Curr Opin Cardiol. 2010. PMID: 20520539 Review.